top of page

Philanthropic partnership unlocks £32 million for the future of best-in-class UK Biobank

Eric Schmidt and Ken Griffin are being announced as the first members of a new consortium that will shape the future of the best-in-class UK Biobank.


Eric Schmidt and Ken Griffin are being announced as the first members of a new consortium that will shape the future of the best-in-class UK Biobank.

Former CEO and Chairman of Google Eric Schmidt, and Ken Griffin, founder and CEO of Citadel and founder of Griffin Catalyst, are today (Monday 30 October) being announced as the first members of a new consortium that will shape the future of the best-in-class UK Biobank, starting with £16 million funding matched by government.

Their donations will support UK Biobank to grow its already-unrivalled wealth of health data, to enable research unlocking the next great leaps in our understanding of health and disease.

This could include using AI’s ability to rapidly analyse vast quantities of data to draw new insights from UK Biobank’s data, such as in the analysis of cancer samples – the sort of uptake of AI in health and research being encouraged by the new AI Life Sciences Accelerator Mission, announced by the Prime Minister, last week.


Comments


Other Science, engineering & technology news

bottom of page